|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:245-249
© 2005 The American Association for Thoracic Surgery
Editorial |
Department of Cardiothoracic Surgery, UCLA Medical Center, Los Angeles, Calif
Received for publication February 24, 2005; accepted for publication March 1, 2005. * Address for reprints: Gerald D. Buckberg, MD, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, 62-258 CHS, Los Angeles, CA 90095 (Email: gbuckberg@mednet.ucla.edu).
| The first 300 words of the full text of this article appear below. |
A recent editorial, the first on this subject, appeared in the Journal
1
: "To STICH or not to STICH: We know the answer, but do we understand the question?" Although the article indicates the answer is "to STICH," this report asks whether the STICH investigators response understood the question.
Patient Selection and Inclusion Criteria
The underlying principle of the STICH (Surgical Treatment for IschemiC Heart failure) trial involves recognition of the potentially lethal complications of enlarging ventricular volume, and its questions are closely linked to volume measurements, the first entry criteria for inclusion in the trial. This fundamental concept stems from the seminal work of White and colleagues,
2
showing how increased left ventricular end-systolic volume affects mortality. For example, Figure 1A shows that doubling of mortality follows doubling of volume and defines how death rate worsens after the progressive end-systolic volume expansion. Measuring ventricular volume is a central ingredient of the STICH trial and is expressed as left ventricular end-systolic volume index (LVESVI) in the database. The congestive heart failure (CHF) community must recognize that this vital measurement reflects a major departure from conventional analysis because ejection fraction is now the traditional marker. White and colleagues
2
have shown, in Figure 1B, the survival discrepancy between conventional ejection fraction and LVESVI measurement. Unfortunately, this central issue is never raised in the invited editorial that just appeared in the Journal.
| |||||||||||
This article has been cited by other articles:
![]() |
R. B. Prucz, E. S. Weiss, N. D. Patel, L. U. Nwakanma, W. A. Baumgartner, and J. V. Conte Coronary Artery Bypass Grafting With or Without Surgical Ventricular Restoration: A Comparison Ann. Thorac. Surg., September 1, 2008; 86(3): 806 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Geissler Invited commentary Ann. Thorac. Surg., October 1, 2007; 84(4): 1287 - 1287. [Full Text] [PDF] |
||||
![]() |
M. Pocar, A. Moneta, A. Grossi, and F. Donatelli Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow-Up Ann. Thorac. Surg., February 1, 2007; 83(2): 468 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Lloyd, G. D. Buckberg, and the RESTORE Group Use of cardiac magnetic resonance imaging in surgical ventricular restoration Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S216 - S224. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |